Trial Profile
Phase 1/2 Clinical Study of MenSCs Infusion in Type 1 Diabetes
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Menstrual blood-derived mesenchymal stem cells (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors S-Evans Biosciences
- 20 May 2015 New trial record